✨ Health Notices




NEW ZEALAND GAZETTE, No. 6

17 JANUARY 2008


Health

Crown Entities Act 2004

Reappointment of the Health and Disability Commissioner

Pursuant to section 28(1)(b) of the Crown Entities Act 2004,
His Excellency the Governor-General of New Zealand has reappointed

Ronald James Paterson

as the Health and Disability Commissioner for a five-year term of office commencing on 5 March 2008 and expiring on 4 March 2013.

This reappointment was made by way of written notice to the Health and Disability Commissioner, pursuant to section 28(2) of the Crown Entities Act 2004.

Dated at Auckland this 17th day of December 2007.

HON. DAVID CUNLIFFE, Minister of Health.

go206


Medicines Act 1981

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Xigris

Active Ingredient:
Drotrecogin alfa (activated) 20mg

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturer:
DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America

Product:
Xigris

Active Ingredient:
Drotrecogin alfa (activated) 5mg

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturer:
DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America

Dated this 14th day of January 2008.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go288


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
5008 bibag for Haemodialysis Solution

Active Ingredient:
Sodium bicarbonate 100%w/w

Dosage Form:
Powder

New Zealand Sponsor:
Fresenius Medical Care Australia Pty Limited

Manufacturer:
Fresenius SMAD, Secteur Ouest, Savigny, L’Arbresle Cede, France

Product:
Apo-Risperidone

Active Ingredient:
Risperidone 0.5mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Risperidone

Active Ingredient:
Risperidone 1mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Risperidone

Active Ingredient:
Risperidone 2mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2008, No 6


Gazette.govt.nz PDF NZ Gazette 2008, No 6





✨ LLM interpretation of page content

πŸ₯ Reappointment of Health and Disability Commissioner

πŸ₯ Health & Social Welfare
17 December 2007
Reappointment, Health and Disability Commissioner, Crown Entities Act 2004
  • Ronald James Paterson, Reappointed Health and Disability Commissioner

  • HON. DAVID CUNLIFFE, Minister of Health

πŸ₯ Consent to Distribution of Changed Medicine

πŸ₯ Health & Social Welfare
14 January 2008
Medicines, Distribution, Xigris, Drotrecogin alfa, Eli Lilly
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
14 January 2008
Medicines, Distribution, Haemodialysis, Risperidone, Fresenius, Apotex
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate